Literature DB >> 26626948

Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophrenia.

Olivia M Dean1, Serafino G Mancuso2, Ashley I Bush3, David Copolov4, Kim Q Do5, Michel Cuénod5, Philippe Conus6, Susan L Rossell7, David J Castle8, Michael Berk9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26626948     DOI： 10.1016/j.psychres.2015.10.037

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


× No keyword cloud information.
  5 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 2.  The Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-Analysis.

Authors:  Kenji Sanada; Iñaki Zorrilla; Yusuke Iwata; Cristina Bermúdez-Ampudia; Ariel Graff-Guerrero; Mónica Martínez-Cengotitabengoa; Ana González-Pinto
Journal:  Int J Mol Sci       Date:  2016-10-24       Impact factor: 5.923

3.  N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms.

Authors:  Susan L Rossell; Paul S Francis; Cherrie Galletly; Anthony Harris; Dan Siskind; Michael Berk; Kiymet Bozaoglu; Frances Dark; Olivia Dean; Dennis Liu; Denny Meyer; Erica Neill; Andrea Phillipou; Jerome Sarris; David J Castle
Journal:  BMC Psychiatry       Date:  2016-09-15       Impact factor: 3.630

4.  Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia.

Authors:  Grant McQueen; John Lally; Tracy Collier; Fernando Zelaya; David J Lythgoe; Gareth J Barker; James M Stone; Philip McGuire; James H MacCabe; Alice Egerton
Journal:  Psychopharmacology (Berl)       Date:  2018-08-23       Impact factor: 4.530

5.  Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia.

Authors:  Grant McQueen; Aderlee Lay; John Lally; Anthony S Gabay; Tracy Collier; David J Lythgoe; Gareth J Barker; James M Stone; Philip McGuire; James H MacCabe; Alice Egerton
Journal:  Psychopharmacology (Berl)       Date:  2019-11-30       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.